Growth Metrics

Bio-Techne (TECH) Operating Income (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Bio-Techne 7.92 Bn 7.71 Bn 208.29 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 38.62%
Dec 31, 2025 14.27%
Sep 30, 2025 299.74%
Jun 30, 2025 -161.64%
Mar 31, 2025 -18.37%
Dec 31, 2024 18.59%
Sep 30, 2024 -12.74%
Jun 30, 2024 -31.61%
Mar 31, 2024 76.29%
Dec 31, 2023 -31.97%
Sep 30, 2023 -40.90%
Jun 30, 2023 17.85%
Mar 31, 2023 18.15%
Dec 31, 2022 20.55%
Sep 30, 2022 -30.10%
Jun 30, 2022 -10.92%
Mar 31, 2022 45.07%
Dec 31, 2021 -1.38%
Sep 30, 2021 -7.82%
Jun 30, 2021 -0.06%
Mar 31, 2021 34.57%
Dec 31, 2020 3.88%
Sep 30, 2020 24.88%
Jun 30, 2020 -17.75%
Mar 31, 2020 29.19%
Dec 31, 2019 11.00%
Sep 30, 2019 -22.97%
Jun 30, 2019 -1.87%
Mar 31, 2019 31.21%
Dec 31, 2018 30.43%
Sep 30, 2018 -39.97%
Jun 30, 2018 -0.39%
Mar 31, 2018 78.42%
Dec 31, 2017 -7.23%
Sep 30, 2017 -35.00%
Jun 30, 2017 19.53%
Mar 31, 2017 87.36%
Dec 31, 2016 -38.67%
Sep 30, 2016 -27.13%
Jun 30, 2016 -8.08%
Mar 31, 2016 20.82%
Dec 31, 2015 16.10%
Sep 30, 2015 -17.92%
Jun 30, 2015 -4.12%
Mar 31, 2015 14.01%
Dec 31, 2014 -1.81%
Sep 30, 2014 -9.34%
Jun 30, 2014 -15.13%
Mar 31, 2014 28.05%
Dec 31, 2013 -9.26%
Sep 30, 2013 163.11%
Jun 30, 2013 -242.04%
Mar 31, 2013 19.08%
Dec 31, 2012 -2.38%
Sep 30, 2012 -8.29%
Jun 30, 2012 -11.10%
Mar 31, 2012 23.03%
Dec 31, 2011 -7.97%
Sep 30, 2011 -3.89%
Jun 30, 2011 -4.77%
Mar 31, 2011 19.78%
Dec 31, 2010 -2.64%
Sep 30, 2010 161.24%
Jun 30, 2010 -250.42%
Mar 31, 2010 13.94%
Dec 31, 2009 -6.75%